Aug 24 (Reuters) - Moderna Inc MRNA.O said on Monday it has concluded advanced exploratory talks with the European Commission to supply 80 million doses of its COVID-19 vaccine candidate.
The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Arun Koyyur)
((firstname.lastname@example.org;; within U.S. +1 646 223 8780, outside U.S. +91 80 6749 6132; Twitter: @AnkurBanerjee17;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
In This StoryMRNA
Latest Markets Videos
- Tesla removed from S&P 500 ESG index on autopilot, discrimination concerns
- US STOCKS-Wall Street ends sharply lower as Target and growth stocks sink
- Fed could cut rates in 2023, 2024 once inflation under control -Bullard
- Powell says Fed to 'keep pushing' rates higher until clear inflation is falling